STAT Plus: Study of experimental heart drug from Cytokinetics, Amgen meets goal — but still disappoints
Cytokinetics and Amgen said their study of an experimental heart drug achieved its main goal, but the treatment effect was marginal.
Copyright © 2021 Biotech Networks, LLC